Should the Pfizer bid fail - the share price could tank - particularly in this market. The last raising was an insto placement in April 2021 at 5.8 cents - so to hang on would mean long term dilution too.
If there was another bidder - they would probably have put their hand up already.
I congratulate the directors for negotiating a better price for shareholders than the original offer.
RAP Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held
